Luther King Capital Management (LKCM)
KYNB icon

Luther King Capital Management (LKCM)’s Kyntra Bio KYNB Stock Holding History

Luther King Capital Management (LKCM)’s Portfolio KYNB Stock Details KYNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-1,396
Closed -$1.9M – 535
2019
Q1 		$1.9M Hold
1,396
– – 0.01% 281
2018
Q4 		$1.62M Hold
1,396
– – 0.01% 282
2018
Q3 		$2.12M Hold
1,396
– – 0.02% 284
2018
Q2 		$2.19M Hold
1,396
– – 0.02% 279
2018
Q1 		$1.61M Buy
+1,396
New +$1.84M 0.01% 303

Other funds holding KYNB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Farallon Capital Management
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Luther King Capital Management (LKCM)'s KYNB Position: Q2 2019 in Review

Luther King Capital Management (LKCM) sold out of Kyntra Bio (KYNB) in Q2 2019, closing a stake of 1,396 shares — an estimated $1.9M sold.

Luther King Capital Management (LKCM) first reported a position in KYNB in Q1 2018 and held it in 5 quarters. The position peaked at $2.19M in Q2 2018. 190 funds tracked by Wall St. Rank hold KYNB as of Q2 2019.

  • Luther King Capital Management (LKCM) reported no remaining Kyntra Bio position as of Q2 2019 after selling out during the quarter.
  • Luther King Capital Management (LKCM) sold 1,396 Kyntra Bio shares in Q2 2019, an estimated $1.9M.
  • Luther King Capital Management (LKCM) first reported a position in Kyntra Bio in Q1 2018 and held it in 5 quarters.
  • Luther King Capital Management (LKCM)'s Kyntra Bio position peaked at $2.19M in Q2 2018.
  • 190 funds tracked by Wall St. Rank held Kyntra Bio as of Q2 2019.

Based on Luther King Capital Management (LKCM)'s 13F filing for Q2 2019, filed 12 Aug 2019.